- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-26-0017172

About Indus Biotech Limited
Data last updated:
Indus Biotech Limited is a public limited company based in Pune, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231MH1995PLC085656. Its GSTIN is 27AAACI5708E1ZT (Maharashtra).
The company has an authorised share capital of ₹43 Cr and a paid-up capital of ₹10.48 Cr. It was formerly known as Indus Biotech Private Limited and Indus Natural Products Private Limited. It is led by directors including Sunil Dutt Bhaskaran (Managing Director) and Rajan Ramaswamy Srinivasan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Rahul Residency Plot Nos. 6 & 7 Off Salunke Vihar Road Kondhwa, Pune, Maharashtra, India – 411048.
As per the financials filed for FY 2025, the company reported a revenue of ₹71.42 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹3.68 Cr (net margin 5.2%) and EBITDA of ₹10.88 Cr (EBITDA margin 15.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The company has about 121 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Indus Biotech. As per MCA filings, the company has open charges of ₹2.93 Cr and satisfied charges of ₹22.02 Cr on record. Court records list 25 cases involving the company, including 15 filed by the company and 10 filed against it; 1 case is pending. The company has 18 deals on record (11 funding rounds, 6 secondary share transfers, 1 acquisition), with disclosed funding of ₹17.26 Cr; the latest was in June 2025. The company has 15 MSME Form 1 returns on record between 2020 and 2024, listing 1,834 overdue payments to 183 micro and small suppliers.
Indus Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0017172). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indusbiotech.com.
Company details
Name history
Indus Biotech has undergone 2 name changes throughout its history. The company was previously known as Indus Biotech Private Limited, and Indus Natural Products Private Limited. The current legal name is Indus Biotech Limited.
| Company Name | Status |
|---|---|
| Indus Biotech Limited | Current |
| Indus Biotech Private Limited | Previous |
| Indus Natural Products Private Limited | Previous |
CIN history
Indus Biotech has one previous CIN (Corporate Identification Number): U24231MH1995PTC085656. The current CIN is U24231MH1995PLC085656, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH1995PLC085656 | Current |
| U24231MH1995PTC085656 | Previous |
Recognitions & Rankings of Indus Biotech
Contact details
Indus Biotech Limited's registered office is in Pune, Maharashtra. Its website is indusbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1 Rahul Residency Plot Nos. 6 & 7 Off Salunke Vihar Road Kondhwa, Pune, Maharashtra, India – 411048
- IndustryLife Sciences, Biotechnology
To see the full contact details of Indus Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Indus Biotech operates one associated brand: Indus Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drugs for autoimmune, CNS, infectious, and lifestyle diseases are developed. | indusbiotech.com |
Business activity
The main business activity of Indus Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indus Biotech Limited, buy the company report.
Financials of Indus Biotech Limited
FY 2025 filings availableIndus Biotech Limited reported revenue of ₹71.42 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.88 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.68 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.2% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indus Biotech Limited, buy the company report.
Board of directors and KMP of Indus Biotech Limited
Indus Biotech Limited currently reports 6 directors and 1 key managerial person. 8 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajan Ramaswamy Srinivasan Also directs: Argon Company Connectivity Services Private Limited | Director | 01 Jan 2001 | 25 Years 10 Months | Current |
| Achyut Jayatirthrao Huilgol Also directs: Trigonella Labs Private Limited | Cfo | 14 Mar 2018 | 8 Years 8 Months | Current |
| Ranjeet Palliyil Srinivasan | Director | 16 Feb 1995 | 31 Years 9 Months | Current |
| Shrikant Jayawant Patil | Director | 15 Nov 2021 | 5 Years 0 Months | Current |
| Anil Pratap Kumar Also directs: Infinity Agriculture and Services Private Limited, Polymermann (Asia) Pvt Ltd, Qualitypower Solutions Private Limited and 5 more | Director | 15 Nov 2021 | 5 Years 0 Months | Current |
| Pankaj Mehra Also directs: Premkutir Private Limited | Director | 26 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Indus Biotech Limited is audited by MSKA & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Indus Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Indus Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2021 | 100459522 | Others | ₹2 Cr | Open | |
| 15 Jun 2017 | 100147555 | Vijaya Bank | ₹92.68 Lakh | Open | |
| 27 Oct 2015 | 10602344 | Others | ₹13.48 Cr | Satisfied | |
| 15 Oct 2011 | 10316247 | Vijaya Bank | ₹52 Lakh | Satisfied | |
| 25 Aug 2009 | 10175309 | Vijaya Bank | ₹4 Cr | Satisfied |
To see the full charge records of Indus Biotech Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Indus Biotech Limited has 18 deals on record (11 funding rounds, 6 secondary share transfers, 1 acquisition), with disclosed funding of ₹17.26 Cr; the latest was in June 2025.
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Seller: Kotak Private Equity |
| Oct 2012 | Secondary share transfer | Undisclosed | Buyer: Kotak Securities Limited Seller: Kotak Mahindra Investments Limited |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Kotak Private Equity Seller: Kotak Mahindra Investments Limited |
| Sep 2008 | Funding round | ₹5.55 Cr | Investors: Kotak Private Equity |
| Sep 2008 | Funding round | ₹12.5 Lakh | Investors: Kotak Private Equity |
To see the full deal history of Indus Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Indus Biotech Limited has 25 court cases on record: 15 filed by Indus Biotech, 10 filed against it. 1 case is pending and 24 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 18 | 8 | 1 |
| District courts | 4 | 0 | 0 |
| Supreme Court | 2 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1101-Arbitration Matters : Arbitration Petitions under Section 11 of Arbitration & Conciliation Act, 1996) | Filed by the company against Kotak Securities Limited Through the Director 27 BKC, 7Th Floor, Plot No. C-27, G Block, Bandra Kurla Complex, Bandra (East), Mumbai ,Mumbai , Maharashtra and 10 others | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by an individual | Pending |
| Supreme Court | Court case (1006-Company Law, Mrtp, Trai, Sebi, Idrai & Rbi : Others) | Filed against the company by Kotak India Venture Fund - I Represented by Its Investment Manager, Having Its Principal Office at 36 - 38A, Nariman Bhavan, 227, Nariman Point, ,Mumbai , Maharashtra | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by Kotak India Venture (Offshore) Fund | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed by the company against Pure and Pristine Solutions Through Partners Shivkumar Aiyer | Disposed |
To see the full case history of Indus Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Indus Biotech Limited has 15 MSME Form 1 returns on record between 2020 and 2024, listing 1,834 overdue payments to 183 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 183)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Universal Calibration Services Private Limited | |||
| B.B.Chemicals Private Limited | |||
| Anatek Services Private Limited | |||
| GK Travels and Services |
To see the full MSME payment records of Indus Biotech Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Indus Biotech has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Trigonella Labs Private Limited | U74999PN2017PTC172331 |
To see the full group structure of Indus Biotech Limited, buy the company report.
Employees & EPFO
Indus Biotech Limited has a workforce of 121 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 121 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Indus Biotech Limited, buy the company report.
GST
Indus Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACI5708E1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Indus Biotech Limited, buy the company report.
Recent activity
Indus Biotech Limited has 15 board changes on record since 1995: 7 appointments and 8 cessations. The latest: Pankaj Mehra ceased to be Additional Director on 29 Sep 2025.
28 earlier events are in the company report.
Frequently asked questions
Indus Biotech is an active public limited company based in Pune, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 February 1995 (31+ years old) and is registered under CIN U24231MH1995PLC085656.
Indus Biotech has 7 current directors and KMP:
- Sunil Dutt Bhaskaran - Managing Director
- Rajan Ramaswamy Srinivasan - Director
- Ranjeet Palliyil Srinivasan - Director
- Shrikant Jayawant Patil - Director
- Anil Pratap Kumar - Director
- Pankaj Mehra - Director
- Achyut Jayatirthrao Huilgol - Cfo
The latest financial statements of Indus Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Indus Biotech is 27AAACI5708E1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indus Biotech is U24231MH1995PLC085656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indus Biotech has 25 court cases on record: 15 filed by the company and 10 filed against it. 1 is pending. Most are in the high courts.
Indus Biotech was incorporated on 16 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Pune.
Indus Biotech has 18 deals on record (11 funding rounds, 6 secondary share transfers, 1 acquisition), with disclosed funding of ₹17.26 Cr; the latest was in June 2025.
Pankaj Mehra ceased to be Additional Director on 29 Sep 2025. Pankaj Mehra was appointed as Director on 26 Sep 2025. Himanshu Nivsarkar ceased to be Nominee Director on 30 Jun 2025. Indus Biotech has 15 board changes on record in total.
Yes, Indus Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-26-0017172).
Indus Biotech has 15 MSME Form 1 returns on record between 2020 and 2024, listing 1,834 overdue payments to 183 micro and small suppliers. The latest return was filed on 29 Apr 2024.

